Prime Medicine Stock (NASDAQ:PRME), Quotes and News Summary

Q: What sector and industry does Prime Medicine (PRME) operate in?

Prime Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Prime Medicine Stock (NASDAQ: PRME) stock price, news, charts, stock research, profile.

Open	$4.340
Close	$4.425
Volume / Avg.	641.595K / 720.020K
Day Range	4.160 - 4.650
52 Wk Range	4.110 - 17.200
Market Cap	$554.119M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	20.02%
Days to Cover	22.49

Recent News

Morgan Stanley Reports Q4 Results, Joins Boeing, Alcoa And Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded lower, with the Dow Jones index falling more than 250 points on Tuesday.

Avi Kapoor

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

Avi Kapoor

Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge Capital Acquisition Corp.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Prime Medicine Inc

Sector

Health Care

Industry

Biotechnology

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Prime Medicine (PRME) stock?

You can purchase shares of Prime Medicine (NASDAQ: PRME) through any online brokerage.

View our list of the best stock brokerages.

Who are Prime Medicine's (PRME) competitors?

Other companies in Prime Medicine’s space includes: Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Cogent Biosciences (NASDAQ:COGT) and Korro Bio (NASDAQ:KRRO).

What is the target price for Prime Medicine (PRME) stock?

The latest price target for Prime Medicine (NASDAQ: PRME) was reported by Wedbush on Tuesday, April 23, 2024. The analyst firm set a price target for 12.00 expecting PRME to rise to within 12 months (a possible 159.74% upside). 12 analyst firms have reported ratings in the last year.

Current Stock Price for Prime Medicine (PRME)?

The stock price for Prime Medicine (NASDAQ: PRME) is $4.62 last updated April 26, 2024 at 7:42 PM EDT.

Does Prime Medicine (PRME) pay a dividend?

A quarterly cash dividend of $0.80 per share of Class A Common Stock. The quarterly cash dividend was payable on September 12, 2019 to stockholders of record on September 10, 2019.

When is Prime Medicine (NASDAQ:PRME) reporting earnings?

Prime Medicine’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Prime Medicine (PRME) going to split?

There is no upcoming split for Prime Medicine.

What sector and industry does Prime Medicine (PRME) operate in?

Prime Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-